Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Melanoma 6Lung Neoplasms 6Prostatic Neoplasms 5Breast Neoplasms 5Multiple Myeloma 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Ovarian Neoplasms 3Osteosarcoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myeloid, Acute 3Barrett Esophagus 3Wilms Tumor 2Urinary Bladder Neoplasms 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Leukemia, Biphenotypic, Acute 2Gastroesophageal Reflux 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Brain Neoplasms 2Adenocarcinoma Of Esophagus 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urethral Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 4Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3liposomal amphotericin B 2fludarabine phosphate 2Microarray Analysis 2Methylprednisolone 2Interferon-alpha 2In Situ Hybridization, Fluorescence 2Filgrastim 2Cytogenetic Analysis 2Cyclosporine 2Caspofungin 2Bortezomib 2Antilymphocyte Serum 2tanespimycin 1siltuximab 1pyroxamide 1piperine 1ibrutinib 1ferrous sulfate 1ferric gluconate 1aldesleukin 1Whole-Body Irradiation 1Watchful Waiting 1Urination 1Topotecan 1Therapeutics 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Monoclonal Gammopathy of Undetermined Significance × Specimen Handling × Clear all
NCT03119883 2024-08-09

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Mayo Clinic

Phase NA Completed
35 enrolled
Plasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡